2024 Q1 Form 10-K Financial Statement

#000121390024025569 Filed on March 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $4.191M $6.137M $24.13M
YoY Change 34.32% 143.23% 51.01%
Cost Of Revenue $974.4K $1.631M $6.492M
YoY Change -33.22% -2.41% 9.11%
Gross Profit $3.217M $4.506M $17.64M
YoY Change 93.65% 428.8% 75.86%
Gross Profit Margin 76.75% 73.43% 73.1%
Selling, General & Admin $6.150M $7.539M $43.17M
YoY Change -50.91% -3.49% 19.98%
% of Gross Profit 191.19% 167.31% 244.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.159M $4.580M $15.07M
YoY Change 62.87% 75.02% 25.19%
% of Gross Profit 129.28% 101.63% 85.44%
Operating Expenses $11.28M $12.12M $73.58M
YoY Change -36.2% 26.99% 36.33%
Operating Profit -$7.092M -$7.617M -$49.45M
YoY Change -51.31% -12.39% 30.16%
Interest Expense $6.522M -$8.883M $18.76M
YoY Change 79.53% 107.37% 248.96%
% of Operating Profit
Other Income/Expense, Net -$7.538M $196.1K -$19.31M
YoY Change 56.18% -80.69% 136.07%
Pretax Income -$14.63M -$19.90M -$68.75M
YoY Change -24.56% 9.42% 48.92%
Income Tax
% Of Pretax Income
Net Earnings -$14.63M -$20.16M -$68.75M
YoY Change -24.56% 8.94% 48.92%
Net Earnings / Revenue -349.06% -328.54% -284.93%
Basic Earnings Per Share -$2.30 -$11.97
Diluted Earnings Per Share -$2.30 -$3.18 -$11.97
COMMON SHARES
Basic Shares Outstanding 6.502M shares 6.435M shares 5.827M shares
Diluted Shares Outstanding 6.486M shares 5.827M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.713M $3.243M $3.243M
YoY Change -63.31% -87.53% -87.53%
Cash & Equivalents $6.884M $11.82M
Short-Term Investments
Other Short-Term Assets $8.109M $3.514M $3.514M
YoY Change 114.32% 5.2% 5.2%
Inventory
Prepaid Expenses
Receivables $1.268M $1.108M $1.108M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.09M $7.866M $7.866M
YoY Change -12.88% -74.76% -74.76%
LONG-TERM ASSETS
Property, Plant & Equipment $341.6M $344.4M $364.1M
YoY Change 35.13% 38.4% 42.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.476M $2.000M
YoY Change -93.19% -90.52%
Other Assets $4.171M $8.573M $8.573M
YoY Change -42.91% 14.31% 14.31%
Total Long-Term Assets $427.5M $434.0M $434.0M
YoY Change -4.43% 2.09% 2.09%
TOTAL ASSETS
Total Short-Term Assets $12.09M $7.866M $7.866M
Total Long-Term Assets $427.5M $434.0M $434.0M
Total Assets $439.6M $441.9M $441.9M
YoY Change -4.68% -3.16% -3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.36M $21.83M $21.83M
YoY Change 38.93% 24.18% 24.18%
Accrued Expenses $3.321M $3.441M $3.441M
YoY Change -2.83% 0.8% 0.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $62.98M $62.98M
YoY Change 4.82% 4.82%
Total Short-Term Liabilities $29.41M $89.54M $89.54M
YoY Change -63.98% 9.29% 9.29%
LONG-TERM LIABILITIES
Long-Term Debt $287.5M $219.5M $219.5M
YoY Change 49.79% 28.15% 28.15%
Other Long-Term Liabilities $9.035M $6.084M $6.084M
YoY Change -41.0% -48.4% -48.4%
Total Long-Term Liabilities $296.6M $225.6M $225.6M
YoY Change 43.08% 23.22% 23.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.41M $89.54M $89.54M
Total Long-Term Liabilities $296.6M $225.6M $225.6M
Total Liabilities $326.0M $315.2M $314.2M
YoY Change 12.82% 18.91% 18.95%
SHAREHOLDERS EQUITY
Retained Earnings -$231.5M -$216.6M
YoY Change 39.03% 47.48%
Common Stock $650.00 $643.00
YoY Change 15.04% 14.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.6M $127.7M $127.7M
YoY Change
Total Liabilities & Shareholders Equity $439.6M $441.9M $441.9M
YoY Change -4.68% -3.16% -3.16%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$14.63M -$20.16M -$68.75M
YoY Change -24.56% 8.94% 48.92%
Depreciation, Depletion And Amortization $4.159M $4.580M $15.07M
YoY Change 62.87% 75.02% 25.19%
Cash From Operating Activities -$2.500M -$7.390M -$27.00M
YoY Change -78.34% 1.15% 451.85%
INVESTING ACTIVITIES
Capital Expenditures $11.09M $7.761M $45.59M
YoY Change 14.62% -55.15% -52.09%
Acquisitions
YoY Change
Other Investing Activities $8.127M $4.490K $17.76M
YoY Change -154.18% -100.03% -204.74%
Cash From Investing Activities -$2.968M -$7.756M -$27.83M
YoY Change -87.97% -77.36% -75.18%
FINANCING ACTIVITIES
Cash Dividend Paid $450.0K
YoY Change -40.0%
Common Stock Issuance & Retirement, Net $39.26K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $512.8K 15.21M $33.13M
YoY Change -97.05% -64.21% -75.12%
NET CHANGE
Cash From Operating Activities -$2.500M -7.390M -$27.00M
Cash From Investing Activities -$2.968M -7.756M -$27.83M
Cash From Financing Activities $512.8K 15.21M $33.13M
Net Change In Cash -$4.955M 59.69K -$21.70M
YoY Change -73.67% -93.46% -234.55%
FREE CASH FLOW
Cash From Operating Activities -$2.500M -$7.390M -$27.00M
Capital Expenditures $11.09M $7.761M $45.59M
Free Cash Flow -$13.59M -$15.15M -$72.59M
YoY Change -35.94% -38.44% -27.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.01
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5826504 shares
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38363
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3235695
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2014 Champions Gateway
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44708
CY2023 dei City Area Code
CityAreaCode
(330)
CY2023 dei Local Phone Number
LocalPhoneNumber
458-9176
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
6401712 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6502308 shares
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
Cleveland, Ohio
CY2023Q4 us-gaap Cash
Cash
3243353 usd
CY2022Q4 us-gaap Cash
Cash
26016547 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8572730 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
7499835 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
17033515 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4067754 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1108460 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1811143 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3514135 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3340342 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
344378835 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248826853 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
12325227 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7387693 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7562048 usd
CY2023Q4 hofv Project Development Costs
ProjectDevelopmentCosts
59366200 usd
CY2022Q4 hofv Project Development Costs
ProjectDevelopmentCosts
140138924 usd
CY2023Q4 us-gaap Assets
Assets
441896633 usd
CY2022Q4 us-gaap Assets
Assets
456296961 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
219532941 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
171315860 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
21825540 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
17575683 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
1293874 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
855485 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
225000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
911000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
62982552 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
60087907 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
200000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3440630 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3413210 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
5858682 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
10679704 usd
CY2023Q4 us-gaap Liabilities
Liabilities
315159219 usd
CY2022Q4 us-gaap Liabilities
Liabilities
265038849 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4917000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4917000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6437020 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6437020 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5604869 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5604869 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
643 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
560 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
344335489 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
339038466 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-216643882 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146898343 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
127692252 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
192140685 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-954838 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-882573 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
126737414 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
191258112 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441896633 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
456296961 usd
CY2023 us-gaap Revenues
Revenues
24129673 usd
CY2022 us-gaap Revenues
Revenues
15979372 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
43171407 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
35982464 usd
CY2023 us-gaap Other General Expense
OtherGeneralExpense
6491625 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
5949839 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8845000 usd
CY2023 us-gaap Depreciation
Depreciation
15069782 usd
CY2022 us-gaap Depreciation
Depreciation
12037374 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
73577814 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
53969677 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-49448141 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-37990305 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6250721 usd
CY2023 us-gaap Accretion Expense
AccretionExpense
6914176 usd
CY2022 us-gaap Accretion Expense
AccretionExpense
1156362 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
244143 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
807877 usd
CY2023 hofv Recognition Of Film Costs
RecognitionOfFilmCosts
160000 usd
CY2023 us-gaap Interest Expense
InterestExpense
18763838 usd
CY2022 us-gaap Interest Expense
InterestExpense
5377146 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3589858 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6250721 usd
CY2023 us-gaap Other Income
OtherIncome
4265937 usd
CY2022 us-gaap Other Income
OtherIncome
604912 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-686000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9422000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
163850 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-200000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-2067754 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6377051 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19305663 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8178006 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68753804 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-46168311 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1064000 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1064000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-72265 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-285807 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-69745539 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46946504 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.97
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.01
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5826504 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5208054 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
204578244 usd
CY2022 hofv Stockbased Compensation On Rsu Restricted Stock Awards And Performance Share Units
StockbasedCompensationOnRSURestrictedStockAwardsAndPerformanceShareUnits
3896803 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28500 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
20403516 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
803061 usd
CY2022 hofv Stock Issued During Period Value Warrants Issued In Connection With Modification Of Notes Payable
StockIssuedDuringPeriodValueWarrantsIssuedInConnectionWithModificationOfNotesPayable
1088515 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
75419 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
18709 usd
CY2022 hofv Share Issued In Connection With Irg Restructuring
ShareIssuedInConnectionWithIRGRestructuring
1310000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3736000 usd
CY2022 hofv Adjustments To Additional Paid In Capital Modification Of Warrants In Connection With Irg Restructuring
AdjustmentsToAdditionalPaidInCapitalModificationOfWarrantsInConnectionWithIRGRestructuring
2670000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1064000 usd
CY2022 hofv Stock Issued During Period Amount Paid For Fractional Shares
StockIssuedDuringPeriodAmountPaidForFractionalShares
-118344 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-46168311 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
191258112 usd
CY2023 hofv Stockbased Compensation On Rsu Restricted Stock Awards And Performance Share Units
StockbasedCompensationOnRSURestrictedStockAwardsAndPerformanceShareUnits
2756849 usd
CY2023 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
14449 shares
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
39261 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2500996 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1064000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68753804 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
126737414 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68753804 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-46168311 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15069782 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12037374 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3577034 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21700299 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4019531 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
729166 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33126304 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133149377 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8845000 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
563652 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
72917 usd
CY2023 us-gaap Paid In Kind Interest
PaidInKindInterest
6671400 usd
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
3969093 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6377051 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
148796 usd
CY2023 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
4117141 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-686000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9422000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
163850 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-200000 usd
CY2023 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2067754 usd
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
67754 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2756849 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3925303 usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
520831 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
179898 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
798752 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
251795 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
357126 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-289396 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2026036 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9924830 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-319056 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
17753 usd
CY2023 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
438389 usd
CY2022 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
3015292 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-383655 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2939079 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27000438 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4892748 usd
CY2023 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
45590651 usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
95167689 usd
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
89470392 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
241691 usd
CY2023 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
71947597 usd
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
16960598 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27826165 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112128287 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
43075339 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
79196400 usd
CY2022 hofv Payment For Fractional Shares
PaymentForFractionalShares
-118344 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5757301 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19256319 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2226310 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11559606 usd
CY2023 hofv Payment For Repurchase Of Interest Rate Swap
PaymentForRepurchaseOfInterestRateSwap
36150 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
450000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
750000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39261 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20777893 usd
CY2022 hofv Proceeds From Failed Sale Leaseback
ProceedsFromFailedSaleLeaseback
65588519 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2500996 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16128342 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33516382 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17388040 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11816083 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33516382 usd
CY2023Q4 us-gaap Cash
Cash
3243353 usd
CY2022Q4 us-gaap Cash
Cash
26016547 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8572730 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
7499835 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11816083 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33516382 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
8958351 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
7377808 usd
CY2023 hofv Project Development Cost Acquired Through Accounts Payable And Accrued Expenses Net
ProjectDevelopmentCostAcquiredThroughAccountsPayableAndAccruedExpensesNet
9028091 usd
CY2022 hofv Project Development Cost Acquired Through Accounts Payable And Accrued Expenses Net
ProjectDevelopmentCostAcquiredThroughAccountsPayableAndAccruedExpensesNet
3346580 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
127453617 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53752242 usd
CY2022 hofv Amendment Of Series C Warrant Liability For Equity Classification
AmendmentOfSeriesCWarrantLiabilityForEquityClassification
3336000 usd
CY2022 hofv Amendment Of Series C And D Warrants
AmendmentOfSeriesCAndDWarrants
400000 usd
CY2023 hofv Accrued Series B Preferred Stock Dividends
AccruedSeriesBPreferredStockDividends
614000 usd
CY2022 hofv Accrued Series B Preferred Stock Dividends
AccruedSeriesBPreferredStockDividends
314000 usd
CY2022 hofv Initial Value Of Right Of Use Asset Upon Adoption Of Asc842
InitialValueOfRightOfUseAssetUponAdoptionOfASC842
7741955 usd
CY2022 hofv Amounts Due To Affiliate Exchanged For Note Payable
AmountsDueToAffiliateExchangedForNotePayable
3978762 usd
CY2022 hofv Accrued Interest Rolled Into Notes Payable In Connection With Modification
AccruedInterestRolledIntoNotesPayableInConnectionWithModification
1437458 usd
CY2022 hofv Shares Issued In Connection With Amendment Of Notes Payable
SharesIssuedInConnectionWithAmendmentOfNotesPayable
803061 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
1088515 usd
CY2022 hofv Shares Issued In Connection With Issuance Of Notes Payable
SharesIssuedInConnectionWithIssuanceOfNotesPayable
75419 usd
CY2022 hofv Warrants Issued In Connection With Issuance Of Notes Payable
WarrantsIssuedInConnectionWithIssuanceOfNotesPayable
18709 usd
CY2022 hofv Shares Issued In Connection With Irg Debt Restructuring
SharesIssuedInConnectionWithIRGDebtRestructuring
1310000 usd
CY2022 hofv Increase In Fair Value Of Warrants In Connection With Irg Debt Restructuring
IncreaseInFairValueOfWarrantsInConnectionWithIRGDebtRestructuring
2670000 usd
CY2022 hofv Penny Warrants Received In Consideration Of Sports Betting Agreement
PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement
4000000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1: Organization, Nature of Business, and Liquidity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Organization and Nature of Business</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hall of Fame Resort &amp; Entertainment Company, a Delaware corporation (together with its subsidiaries, unless the context indicates otherwise, the “Company” or “HOFRE”), was incorporated in Delaware as GPAQ Acquisition Holdings, Inc., a wholly owned subsidiary of our legal predecessor, Gordon Pointe Acquisition Corp. (“GPAQ”), a special purpose acquisition company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2020, the Company consummated a business combination with HOF Village, LLC, a Delaware limited liability company (“HOF Village”), pursuant to an Agreement and Plan of Merger dated September 16, 2019 (as amended on November 6, 2019, March 10, 2020 and May 22, 2020, the “Merger Agreement”), by and among the Company, GPAQ, GPAQ Acquiror Merger Sub, Inc., a Delaware corporation (“Acquiror Merger Sub”), GPAQ Company Merger Sub, LLC, a Delaware limited liability company (“Company Merger Sub”), HOF Village and HOF Village Newco, LLC, a Delaware limited liability company (“Newco”). The transactions contemplated by the Merger Agreement are referred to as the “Business Combination”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a resort and entertainment company leveraging the power and popularity of professional football and its legendary players in partnership with the National Football Museum, Inc., doing business as the Pro Football Hall of Fame (“PFHOF”). Headquartered in Canton, Ohio, the Company owns the DoubleTree by Hilton located in downtown Canton and the Hall of Fame Village, which is a multi-use sports, entertainment, and media destination centered around the PFHOF’s campus. The Company is pursuing a differentiation strategy across three pillars, including destination-based assets, HOF Village Media Group, LLC (“Hall of Fame Village Media”), and gaming.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into multiple agreements with PFHOF, and certain government entities, which outline the rights and obligations of each of the parties with regard to the property on which the Hall of Fame Village sits, portions of which are owned by the Company and portions of which are net leased to the Company by government and quasi-governmental entities (see Note 9 for additional information). Under these agreements, the PFHOF and the lessor entities are entitled to use portions of the Hall of Fame Village on a direct-cost basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Reverse Stock Split</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 27, 2022, the Company effectuated a reverse stock split of its shares of common stock at a ratio of 1-for-22. See Note 5, Stockholders’ Equity, for additional information. As a result, the number of shares and income (loss) per share disclosed throughout this Annual Report on Form 10-K have been retrospectively adjusted to reflect the reverse stock split.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Liquidity and Going Concern</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has sustained recurring losses through December 31, 2023 and the Company’s accumulated deficit was $216,643,882 as of such date. Since inception, the Company’s operations have been funded principally through the issuance of debt and equity. As of December 31, 2023, the Company had approximately $3.2 million of unrestricted cash and $8.6 million of restricted cash. The Company has approximately $62.1 million of debt coming due through December 31, 2024. In January 2024, the Company provided notice to IRG and its affiliated lenders to extend the maturity of $49.5 million of principal of its debt until March 31, 2025. The Company is currently working with its lenders to document such extension. During the year ended December 31, 2023, the Company used cash for operating activities of $27,000,438.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 11, 2024, HOF Village completed the sale to Sandlot Facilities, LLC (“Sandlot”) for a $10 million purchase price, subject to adjustment (the “Purchase Price”), of 80% of a newly formed limited liability company named Sandlot HOFV Canton SC, LLC (“Sports Complex Newco”), to which the Company, HOF Village and HOF Village Youth Fields, LLC had contributed the ForeverLawn Sports Complex business prior to closing (the “Transaction”). The Transaction occurred pursuant to the terms of the previously disclosed Membership Interest Purchase Agreement, dated December 22, 2023 (the “Purchase Agreement”), among the Company, HOF Village, Sandlot and Sandlot Youth Sports Holdings, LLC (“Purchaser Guarantor”). Under the Purchase Agreement, Sandlot held back $1.5 million of the Purchase Price (the “Holdback Amount”) to secure certain indemnification obligations of the Company and HOF Village, which holdback will be released by Sandlot for the benefit of HOF Village in three $500,000 increments at 6, 12 and 18 months after the January 11, 2024 closing date of the Transaction (the “Closing”), subject to post-Closing adjustment of the Purchase Price and any indemnification claims pursuant to the Purchase Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects that it will need to raise additional financing to accomplish its development plan and fund its working capital. The Company is seeking to obtain additional funding through debt, construction lending, and equity financing. There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to meet its obligations as they come due for at least one year from the issuance of these consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Basis of Presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements of the Company for the years ended December 31, 2023 and 2022 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the United States Securities and Exchange Commission (“SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and activity of the Company and its wholly owned subsidiaries. Investments in a variable interest entity in which the Company is not the primary beneficiary, or where the Company does not own a majority interest but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. All intercompany profits, transactions, and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company owns a 60% interest in Mountaineer GM, LLC (“Mountaineer”), whose results are consolidated into the Company’s results of operations. The portion of Mountaineer’s net income (loss) that is not attributable to the Company is included in non-controlling interest.</span></p>
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-216643882 usd
CY2023Q4 us-gaap Cash
Cash
3200000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8600000 usd
CY2023Q4 us-gaap Debt Securities
DebtSecurities
62100000 usd
CY2023Q4 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
49500000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27000438 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates and assumptions for the Company relate to credit losses, depreciation, costs capitalized to project development costs, useful lives of long-lived assets, impairment, accounting for debt modifications and extinguishments, stock-based compensation, and fair value of financial instruments (including the fair value of the Company’s warrant liability). Management adjusts such estimates when facts and circumstances dictate. Actual results could differ from those estimates.</span></p>
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-9422000 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
911000 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-686000 usd
CY2023Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
225000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
7700000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8572730 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
7499835 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
17033515 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4067754 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
243081 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
5575700 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
697010 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
484468 usd
CY2023 us-gaap Payments For Film Costs
PaymentsForFilmCosts
1305000 usd
CY2022 us-gaap Payments For Film Costs
PaymentsForFilmCosts
0 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
225000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
911000 usd
CY2022Q4 us-gaap Interest Rate Fair Value Hedge Liability At Fair Value
InterestRateFairValueHedgeLiabilityAtFairValue
200000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4067754 usd
CY2021Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
13669000 usd
CY2022 hofv Amendment Of Series C Warrant Liability For Equity Classification
AmendmentOfSeriesCWarrantLiabilityForEquityClassification
3336000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13082959 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5841811 shares
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
433450980 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
310503989 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
10000000 usd
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.125 pure
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
3.66
CY2023Q4 us-gaap Federal Home Loan Bank Advances Interest Rate
FederalHomeLoanBankAdvancesInterestRate
0.075 pure
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
76746918 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61677136 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
356704062 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
248826853 usd
CY2023Q4 hofv Project Development Costs
ProjectDevelopmentCosts
59366200 usd
CY2022Q4 hofv Project Development Costs
ProjectDevelopmentCosts
140138924 usd
CY2023Q4 hofv Interest Rate Of Held For Sale
InterestRateOfHeldForSale
0.80 pure
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
12325227 usd
CY2023 us-gaap Depreciation
Depreciation
15069782 usd
CY2022 us-gaap Depreciation
Depreciation
12037374 usd
CY2023 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization
47985893 usd
CY2022 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortization
65221191 usd
CY2023 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
127453617 usd
CY2022 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
53803747 usd
CY2023Q4 us-gaap Theatrical Film Costs Development
TheatricalFilmCostsDevelopment
200000 usd
CY2022Q4 us-gaap Theatrical Film Costs Development
TheatricalFilmCostsDevelopment
982000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
229185010 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9652069 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
219532941 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
185195572 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13879712 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
171315860 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3589858 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6250721 usd
CY2023 us-gaap Paid In Kind Interest
PaidInKindInterest
6671400 usd
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
3969093 usd
CY2022 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
38000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
4600000 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
804713 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
966062 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
18100000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6800000 usd
CY2022Q4 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.01 pure
CY2023 hofv Common Stock Issued To Related Party Maximum Requirement Percentage
CommonStockIssuedToRelatedPartyMaximumRequirementPercentage
0.1999 pure
CY2022Q2 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
5681 shares
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
10000000 usd
CY2022Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.04 pure
CY2023Q3 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
2000000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
4000000 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
6000000 usd
CY2023 us-gaap Stockholders Equity Other
StockholdersEquityOther
118344 usd
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
300000000 shares
CY2020Q4 hofv Stockholder Approval
StockholderApproval
5000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
67.32
CY2020Q3 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
82397 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
181818 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
275000 shares
CY2023 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
252418 shares
CY2022 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
90643 shares
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
110000 shares
CY2021Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4878 shares
CY2023Q4 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
39016766 usd
CY2023Q4 hofv Underwriting Agreement Duration Period
UnderwritingAgreementDurationPeriod
P90D
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.75
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
40000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2812500 usd
CY2023Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2500996 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200240 usd
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
121571 usd
CY2022Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
151.8
CY2023 hofv Relative Rights Of Equity Percentage
RelativeRightsOfEquityPercentage
0.07 pure
CY2023Q1 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1600000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
800 shares
CY2023Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
800000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
800 shares
CY2023Q2 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
800000 usd
CY2020Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
750000 usd
CY2022Q2 hofv Received Notice Amount
ReceivedNoticeAmount
4750000 usd
CY2023Q4 hofv Received Notice Amount
ReceivedNoticeAmount
2870000 usd
CY2023 hofv Recognized A Gain Net Book Value
RecognizedAGainNetBookValue
4100000 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
208275 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
154131 usd
CY2020Q4 hofv Agreement Term
AgreementTerm
P10Y
CY2021Q2 us-gaap Retail Land Sales Installment Method Sales Value
RetailLandSalesInstallmentMethodSalesValue
103095 usd
CY2021Q2 hofv Number Of Notes Payable
NumberOfNotesPayable
1 pure
CY2022Q3 hofv Online Market Access Agreement Term
OnlineMarketAccessAgreementTerm
P10Y
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
3600000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
4125000 usd
CY2023Q4 hofv Activation Fund Reserves
ActivationFundReserves
126685 usd
CY2022Q4 hofv Activation Fund Reserves
ActivationFundReserves
3511185 usd
CY2023Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
5441640 usd
CY2022Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
6867970 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
290357 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
300549 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
5858682 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
10679704 usd
CY2023 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
3185240 usd
CY2021Q1 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
203278 usd
CY2023 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8: Contingencies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the normal course of its business, the Company is subject to occasional legal proceedings and claims. The Company does not have any pending litigation that, separately or in the aggregate, would, in the opinion of management, have a material adverse effect on its results of operations, financial condition, or cash flows.</span></p>
CY2023Q4 hofv Percentage Of Development Costs
PercentageOfDevelopmentCosts
0.04 pure
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
3127304 usd
CY2023Q4 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
600000 usd
CY2023Q4 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
600000 usd
CY2023Q4 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
600000 usd
CY2023Q4 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
600000 usd
CY2023Q4 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
750000 usd
CY2023Q4 us-gaap Other Commitment Due After Fifth Year
OtherCommitmentDueAfterFifthYear
6000000 usd
CY2023Q4 us-gaap Other Commitment
OtherCommitment
9150000 usd
CY2023 hofv Annual License Fee
AnnualLicenseFee
600000 usd
CY2022 hofv Annual License Fee
AnnualLicenseFee
900000 usd
CY2022Q4 us-gaap Area Of Land
AreaOfLand
1.64 sqm
CY2023 hofv Percentage Of Bear Interest
PercentageOfBearInterest
0.125 pure
CY2023Q4 us-gaap Percentage Of Unamortized Film Costs
PercentageOfUnamortizedFilmCosts
0.25 pure
CY2023 hofv Common Stock Issued To Related Party Maximum Requirement Percentage
CommonStockIssuedToRelatedPartyMaximumRequirementPercentage
0.1999 pure
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7387693 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7562048 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3440630 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3413210 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
521939 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
470171 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
240234 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
318298 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P90Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P91Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
317994 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
315104 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
311900 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
311900 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
340400 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
40784600 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
42381898 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
38941268 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3440630 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
79219467 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
58419904 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
5056214 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1983382 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
74163253 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
56436522 usd
CY2023 us-gaap Lease Income
LeaseIncome
730348 usd
CY2022 us-gaap Lease Income
LeaseIncome
90369 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
921552 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
887570 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
892159 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
872356 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
698568 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
2662249 usd
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
6934454 usd
CY2022Q3 us-gaap Sale Leaseback Transaction Lease Term
SaleLeasebackTransactionLeaseTerm
P99Y
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
307125 usd
CY2022Q3 hofv Annual Increases
AnnualIncreases
0.02 pure
CY2022Q4 us-gaap Payments For Rent
PaymentsForRent
4375000 usd
CY2023Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.1025 pure
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
62982552 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2200060745 usd
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2137078193 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
60087907 usd
CY2022 us-gaap Lease Cost
LeaseCost
2204080276 usd
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2143992369 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
45041986 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33046546 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4297582 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3109971 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2103659 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1709988 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
231437 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
175345 usd
CY2023Q4 hofv Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
790485 usd
CY2022Q4 hofv Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
784185 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
591387 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
15566 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
15566 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
53072102 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38841611 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
768657 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1623765 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1737381 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1623765 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2506038 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
51448337 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
36335563 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51448337 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36335563 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
214485646 usd
CY2023 hofv Us Federal Net Operating Loss Carryforwards Begins To Expire
USFederalNetOperatingLossCarryforwardsBeginsToExpire
Indefinite
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
217599111 usd
CY2023 hofv Us Local Net Operating Loss Carryforwards Begins To Expire
USLocalNetOperatingLossCarryforwardsBeginsToExpire
P2026Y
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
157364504 usd
CY2022 hofv Us Federal Net Operating Loss Carryforwards Begins To Expire
USFederalNetOperatingLossCarryforwardsBeginsToExpire
Indefinite
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
157466908 usd
CY2022 hofv Us Local Net Operating Loss Carryforwards Begins To Expire
USLocalNetOperatingLossCarryforwardsBeginsToExpire
P2026Y
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
15112774 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23474643 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.02 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.02 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.001 pure
CY2022 hofv Effective Income Tax Rate Reconciliation Deductions Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationDeductionsExtinguishmentOfDebt
0.018 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Assets
EffectiveIncomeTaxRateReconciliationDispositionOfAssets
0.004 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Assets
EffectiveIncomeTaxRateReconciliationDispositionOfAssets
0.007 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.002 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.047 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.008 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.256 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.22 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.509 pure
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
191073 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
192271 usd
CY2024Q1 hofv Tenant Beneficial Membership Percentage
TenantBeneficialMembershipPercentage
0.20 pure
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2024Q1 us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
1000000 usd
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
22040000 usd
CY2023Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.97
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5208054 shares
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023 hofv Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
usd
CY2023 hofv Stock Issued During Period Vlaue Cancellation Of Fractional
StockIssuedDuringPeriodVlaueCancellationOfFractional
usd
CY2022 hofv Recognition Of Film Costs
RecognitionOfFilmCosts
usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2023 hofv Payment For Fractional Shares
PaymentForFractionalShares
usd
CY2022 hofv Payment For Repurchase Of Interest Rate Swap
PaymentForRepurchaseOfInterestRateSwap
usd
CY2023 hofv Proceeds From Failed Sale Leaseback
ProceedsFromFailedSaleLeaseback
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 hofv Amendment Of Series C Warrant Liability For Equity Classification
AmendmentOfSeriesCWarrantLiabilityForEquityClassification
usd
CY2023 hofv Amendment Of Series C And D Warrants
AmendmentOfSeriesCAndDWarrants
usd
CY2023 hofv Initial Value Of Right Of Use Asset Upon Adoption Of Asc842
InitialValueOfRightOfUseAssetUponAdoptionOfASC842
usd
CY2023 hofv Amounts Due To Affiliate Exchanged For Note Payable
AmountsDueToAffiliateExchangedForNotePayable
usd
CY2023 hofv Accrued Interest Rolled Into Notes Payable In Connection With Modification
AccruedInterestRolledIntoNotesPayableInConnectionWithModification
usd
CY2023 hofv Shares Issued In Connection With Amendment Of Notes Payable
SharesIssuedInConnectionWithAmendmentOfNotesPayable
usd
CY2023 us-gaap Notes Issued1
NotesIssued1
usd
CY2023 hofv Shares Issued In Connection With Issuance Of Notes Payable
SharesIssuedInConnectionWithIssuanceOfNotesPayable
usd
CY2023 hofv Warrants Issued In Connection With Issuance Of Notes Payable
WarrantsIssuedInConnectionWithIssuanceOfNotesPayable
usd
CY2023 hofv Shares Issued In Connection With Irg Debt Restructuring
SharesIssuedInConnectionWithIRGDebtRestructuring
usd
CY2023 hofv Increase In Fair Value Of Warrants In Connection With Irg Debt Restructuring
IncreaseInFairValueOfWarrantsInConnectionWithIRGDebtRestructuring
usd
CY2023 hofv Penny Warrants Received In Consideration Of Sports Betting Agreement
PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement
usd
CY2023Q4 us-gaap Interest Rate Fair Value Hedge Liability At Fair Value
InterestRateFairValueHedgeLiabilityAtFairValue
usd
CY2023Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
usd
CY2023Q4 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2030-07-01
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 hofv Effective Income Tax Rate Reconciliation Deductions Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationDeductionsExtinguishmentOfDebt
pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001708176

Files In Submission

Name View Source Status
0001213900-24-025569-index-headers.html Edgar Link pending
0001213900-24-025569-index.html Edgar Link pending
0001213900-24-025569.txt Edgar Link pending
0001213900-24-025569-xbrl.zip Edgar Link pending
ea0201032-10k_hall.htm Edgar Link pending
ea020103201ex10-104_hallof.htm Edgar Link pending
ea020103201ex10-105_hallof.htm Edgar Link pending
ea0201032-10k_hall_htm.xml Edgar Link completed
ea020103201ex10-106_hallof.htm Edgar Link pending
ea020103201ex10-107_hallof.htm Edgar Link pending
ea020103201ex10-38_hallof.htm Edgar Link pending
ea020103201ex10-39_hallof.htm Edgar Link pending
ea020103201ex10-40_hallof.htm Edgar Link pending
ea020103201ex10-41_hallof.htm Edgar Link pending
ea020103201ex10-42_hallof.htm Edgar Link pending
ea020103201ex10-43_hallof.htm Edgar Link pending
ea020103201ex10-44_hallof.htm Edgar Link pending
ea020103201ex10-68_hallof.htm Edgar Link pending
ea020103201ex10-95_hallof.htm Edgar Link pending
ea020103201ex21-1_hallof.htm Edgar Link pending
ea020103201ex23-1_hallof.htm Edgar Link pending
ea020103201ex23-2_hallof.htm Edgar Link pending
ea020103201ex31-1_hallof.htm Edgar Link pending
ea020103201ex31-2_hallof.htm Edgar Link pending
ea020103201ex32_hallof.htm Edgar Link pending
ea020103201ex4-16_hallof.htm Edgar Link pending
ea020103201ex97-01_hallof.htm Edgar Link pending
ex97-01_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hofv-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
hofv-20231231_cal.xml Edgar Link unprocessable
hofv-20231231_def.xml Edgar Link unprocessable
hofv-20231231_lab.xml Edgar Link unprocessable
hofv-20231231_pre.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable